Cardiologists

• Electrocardiograph + sphygmomanometer1902–1940

  Electrocardiograph + sphygmomanometer (the founding instruments of the specialty)

  The string galvanometer ECG and the bedside blood pressure cuff created cardiology as a distinct practice. Before these tools, a "heart specialist" was simply an internist with more listening experience. After them, the cardiologist was someone who could render quantitative, reproducible cardiovascular data: the P-QRS-T waveform for rhythm and conduction, and the systolic and diastolic pressure numbers for hypertension and valvular disease. The first ECG machine at a US hospital arrived at Massachusetts General in 1908; by 1930 the ECG was present in most teaching hospitals and had been proven to identify myocardial infarction from ST patterns. The sphygmomanometer standardized hypertension diagnosis, making blood pressure management a cardiologist's core task for the first time.

  Effect on the work

  The ECG created the first class of interpretive specialist in cardiology. Electrocardiographers joined hospital payrolls in the 1920s-1930s as a distinct role, analogous to the radiographer: someone with technical training in the instrument and its diagnostic interpretation. Cardiology fellowship training programs, first formalized in the 1940s, were built around mastering ECG interpretation and the physiological principles the instrument revealed.

• Coronary arteriography + cardiac cathet…1958–1977

  Coronary arteriography + cardiac catheterization (F. Mason Sones, Cleveland Clinic, 1958)

  On October 30, 1958, F. Mason Sones at the Cleveland Clinic accidentally injected contrast dye directly into a patient's right coronary artery while attempting an aortic root injection. The coronary tree, visible for the first time in a living patient, appeared on fluoroscopy without causing the predicted ventricular fibrillation. Sones recognized what he had witnessed and spent the next two years developing a safe, reproducible technique for selective coronary arteriography. By 1962, cardiac catheterization was spreading to major teaching hospitals; by the late 1960s it was considered a standard workup for suspected coronary artery disease. The cath lab created an entirely new procedural dimension to cardiology: cardiologists became both diagnosticians and interventionists, performing invasive measurements of hemodynamics and anatomy that no prior technology could provide. Coronary surgery (CABG, first successfully performed in 1967 by Rene Favaloro at the Cleveland Clinic using the left internal mammary artery technique) was made possible by Sones's coronary arteriography.

  Effect on the work

  The cardiac catheterization laboratory created a new subspecialty within cardiology (invasive/interventional) and drove demand for cardiologist training. Federal grants partially subsidized hundreds of practitioner cardiologists during the 1950s and thousands during the 1960s. The ACC membership grew substantially through this era as the clinical utility of the specialty became undeniable.

• Coronary Care Unit + DC defibrillator1962–1985

  Coronary Care Unit + DC defibrillator (Bernard Lown 1962; CCU mortality data 1967)

  Desmond Julian founded the first coronary intensive care unit in Sydney in October 1961; the concept rapidly spread to North America through 1962. Bernard Lown at Harvard's Peter Bent Brigham Hospital contributed the direct-current defibrillator (published 1962), which proved a specific DC waveform could reliably reverse ventricular fibrillation without injuring the myocardium. His cardioversion technique, published in 1963, became immediately standard. Lown also introduced lidocaine for arrhythmia control in the CCU setting. A landmark study by Killip and Kimball attributed a nearly 20% reduction in post-MI in-hospital mortality to CCU care. The CCU created a new work environment for cardiologists: not the ambulatory clinic or the catheterization suite, but the intensive monitoring ward where continuous ECG surveillance, immediate defibrillation, and aggressive arrhythmia management kept post-MI patients alive through the first 72 hours. Cardiology became a 24-hour hospital specialty for the first time.

  Effect on the work

  The CCU dramatically elevated the perceived value of cardiologist oversight for hospitalized cardiac patients and drove hospital investment in cardiology departments. It created demand for cardiologists capable of both procedural competence (defibrillation, temporary pacing) and intensive clinical management. The CCU model became the template for the modern academic cardiovascular program.

• PTCA balloon angioplasty + coronary ste…1977–1995

  PTCA balloon angioplasty + coronary stent (Gruentzig 1977; stent 1986; ICD 1980)

  On September 16, 1977, Andreas Gruentzig performed the first percutaneous transluminal coronary angioplasty (PTCA) on an awake patient at the University Hospital in Zurich, dilating an 80% stenosis in the left anterior descending artery with a balloon-tipped catheter. This was the birth of interventional cardiology as a distinct sub-subspecialty. The implantable cardioverter-defibrillator (ICD), first implanted in a human patient by Michel Mirowski in 1980, gave electrophysiologists a curative therapy for malignant arrhythmias. The coronary stent followed in 1986 (Jacques Puel and Ulrich Sigwart independently), solving PTCA's acute closure and restenosis limitations. By the late 1980s, percutaneous coronary intervention (PCI) was established as an alternative to bypass surgery for single-vessel disease. The 1990 ACME trial and 1997 BARI trial defined PCI vs. CABG indications that governed cardiology practice for two decades. Drug-eluting stents arrived in 2003. The procedural era created the modern interventional cardiologist, who operated in the cath lab rather than at the bedside, and drove the Dartmouth Atlas's documentation of more than 100% growth in the cardiologist workforce between 1980 and 1995.

  Effect on the work

  The procedural transformation of cardiology was the single largest workforce driver in the specialty's history. The cardiologist workforce grew from approximately 7,500 in 1980 to over 15,500 by 1995, more than doubling in 15 years. Interventional cardiology (38% of the 1996 workforce) and electrophysiology (6%) became distinct fellowship training tracks within the existing cardiology subspecialty.

• Statins + evidence-based prevention1987–2005

  Statins + evidence-based prevention (lovastatin 1987 FDA approval; ACC/AHA guidelines era)

  The FDA approved lovastatin (Mevacor) on September 1, 1987, the first HMG-CoA reductase inhibitor (statin) approved for clinical use. The 4S trial (1994), CARE (1996), LIPID (1998), and WOSCOPS (1995) trials proved statin therapy reduced major adverse cardiovascular events by 25-35% in primary and secondary prevention populations. Statins became the highest-revenue drug class in pharmaceutical history by the early 2000s (atorvastatin alone was an $11 billion per year drug). For cardiologists, statins transformed the outpatient clinic: managing lipid-lowering therapy and titrating statin doses became a central ambulatory cardiology task, and the ACC/AHA guidelines process (formalized in the early 1990s) created a reference standard for evidence-based cardiovascular medicine that cardiologists were expected to master and apply. The evidence-based medicine era also created a new tool: the randomized controlled trial as the determinant of cardiologist practice, adjudicated through meta-analyses published in the New England Journal of Medicine, JACC, and Circulation.

  Effect on the work

  Statins expanded cardiology's preventive role from a narrow specialist consultation (the patient with symptomatic CAD) to a population-health function covering tens of millions of patients with elevated cardiovascular risk. This breadth made cardiologists more central to primary care decision-making and created demand for preventive cardiology as a sub-subspecialty.

• Digital echocardiography + cardiac imag…2000–2020

  Digital echocardiography + cardiac imaging revolution (CT coronary angiography, cardiac MRI, nuclear PET)

  The 2000s and 2010s completed the transformation of cardiovascular imaging from an art form to a quantitative science. Digital echocardiography with tissue Doppler, 3D reconstruction, and speckle tracking global longitudinal strain (GLS) made LVEF measurement reproducible across centers. Cardiac CT angiography, enabled by 64-slice CT scanners (2004), visualized coronary anatomy non-invasively, and HeartFlow's FFR-CT (FDA cleared 2014) added hemodynamic modeling. Cardiac MRI established myocardial fibrosis quantification via late gadolinium enhancement as a prognostic marker for heart failure and cardiomyopathy. PET/CT perfusion imaging resolved ambiguous nuclear stress test findings. The cardiologist of 2015 had access to a multi-modality cardiovascular imaging toolkit that physicians of 1990 could not have imagined, each modality with its own technical vocabulary, guideline indications, and interpretation standards. Non-invasive imaging and nuclear cardiology became distinct sub-subspecialties, reducing the share of cases requiring invasive diagnostic catheterization.

  Effect on the work

  The imaging revolution drove continued cardiology subspecialization and created demand for cardiologists with advanced imaging fellowship training. It also contributed to rising healthcare costs in cardiovascular medicine, drawing regulatory scrutiny from CMS and commercial payers that ultimately compressed reimbursement for stress testing and imaging in the 2010s.

• AI cardiology2018–present

  AI cardiology: ECG-AI, AI-echo, FFR-CT, wearable ECG, ambient documentation (AI-native era)

  The AI era in cardiology arrived earlier and more substantively than in most medical specialties, because cardiology already had rich signal data (the ECG, echocardiography waveforms, CCTA scans) that neural networks could learn from. Ertl et al.'s Mayo Clinic paper in Nature Medicine (2018) demonstrated that an AI algorithm could detect low ejection fraction from a standard 12-lead ECG with AUC 0.93, outperforming expert cardiologists at a task previously thought to require an echocardiogram. Cardiologs (GE Healthcare, acquired 2021) deployed AI-ECG analysis at 1,000+ hospitals globally. Ultromics EchoGo and Us2.ai auto-populated echocardiography quantitative measurements, reducing echo read time from 15-20 minutes to 3-5 minutes. HeartFlow FFR-CT eliminated diagnostic catheterization for 12-20% of intermediate-risk stable CAD patients (ADVANCE trial, JACC 2025). Consumer wearables, including the Apple Watch ECG app (FDA cleared 2018) and AliveCor KardiaMobile 6L, created a new category of cardiologist work: interpreting patient-submitted single-lead ECG strips from millions of users. Ambient AI scribes (Dragon Copilot, Abridge) addressed cardiology's top burnout driver, documentation, by auto-generating structured clinical notes. The ACC published formal guidance on AI in cardiology in 2023, updated 2025, establishing that cardiologists retain diagnostic authority and malpractice liability for AI-assisted decisions.

  Effect on the work

  AI augments rather than displaces in the current environment, but the augmentation is substantive: AI-ECG programs enable cardiologists to oversee 10x more remote ECG readings per day than pre-AI. Documentation AI recaptures 60-90 minutes per cardiologist per day. The structural demand driver (aging population, rising cardiovascular disease prevalence) and the ongoing AAMC-projected shortage suggest that AI compression of the diagnostic interpretation workload will be absorbed into greater patient volume per cardiologist rather than workforce reduction.

What's changing in your day

Three parts of your work where AI is already doing real lifting, and what stays yours.